Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE HealthCare
GEHC
|
+$484M |
| 2 |
Microsoft
MSFT
|
+$417M |
| 3 |
Amazon
AMZN
|
+$365M |
| 4 |
Apple
AAPL
|
+$357M |
| 5 |
Merck
MRK
|
+$311M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$420M |
| 2 |
SIVB
SVB Financial Group
SIVB
|
+$288M |
| 3 |
Philip Morris
PM
|
+$246M |
| 4 |
Canadian Pacific Kansas City
CP
|
+$228M |
| 5 |
Meta Platforms (Facebook)
META
|
+$208M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.14% |
| 2 | Healthcare | 13.96% |
| 3 | Financials | 12.57% |
| 4 | Consumer Discretionary | 10.55% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Talos Energy
TALO
$2.4B
| $18.7M | ﹤0.01% |
1,258,072
+93,677
| +8% | +$1.61M |
|
|
ARGO
1852
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $18.7M | ﹤0.01% |
637,172
+21,819
| +4% | +$618K |
|
|
INVX
1853
Innovex International
INVX
$1.97B
| $18.6M | ﹤0.01% |
647,954
+27,941
| +5% | +$828K |
|
1854
Iovance Biotherapeutics
IOVA
$2.83B
| $18.6M | ﹤0.01% |
3,039,433
+233,052
| +8% | +$1.61M |
|
1855
AMERISAFE
AMSF
$540M
| $18.6M | ﹤0.01% |
379,184
+22,331
| +6% | +$1.17M |
|
|
CHCT
1856
Community Healthcare Trust
CHCT
$454M
| $18.6M | ﹤0.01% |
507,090
+9,433
| +2% | +$368K |
|
1857
Comstock Resources
CRK
$3.94B
| $18.5M | ﹤0.01% |
1,713,764
+97,022
| +6% | +$1.15M |
|
1858
German American Bancorp
GABC
$1.9B
| $18.5M | ﹤0.01% |
553,996
+18,621
| +3% | +$692K |
|
1859
John B. Sanfilippo & Son
JBSS
$972M
| $18.4M | ﹤0.01% |
190,203
+5,603
| +3% | +$500K |
|
1860
Virgin Galactic
SPCE
$398M
| $18.4M | ﹤0.01% |
227,489
+12,761
| +6% | +$1.27M |
|
1861
indie Semiconductor
INDI
$854M
| $18.4M | ﹤0.01% |
1,746,182
+153,745
| +10% | +$1.37M |
|
1862
Liberty Media Series A
FWONA
$23.5B
| $18.4M | ﹤0.01% |
284,892
+14,082
| +5% | +$849K |
|
1863
Shenandoah Telecom
SHEN
$746M
| $18.4M | ﹤0.01% |
965,733
+36,381
| +4% | +$680K |
|
1864
Apogee Enterprises
APOG
$908M
| $18.4M | ﹤0.01% |
424,472
+22,526
| +6% | +$1.01M |
|
|
FLNA
1865
Filana Therapeutics
FLNA
$48.1M
| $18.3M | ﹤0.01% |
758,956
+50,164
| +7% | +$1.39M |
|
1866
Recursion Pharmaceuticals
RXRX
$1.72B
| $18.3M | ﹤0.01% |
2,743,484
+133,536
| +5% | +$1.06M |
|
1867
Empire State Realty Trust
ESRT
$836M
| $18.2M | ﹤0.01% |
2,805,024
+80,543
| +3% | +$590K |
|
1868
Ginkgo Bioworks
DNA
$521M
| $18.2M | ﹤0.01% |
342,160
+47,784
| +16% | +$3.03M |
|
|
GDEN
1869
DELISTED
Golden Entertainment
GDEN
| $18.2M | ﹤0.01% |
418,022
+17,736
| +4% | +$718K |
|
1870
The GEO Group
GEO
$4.1B
| $18.2M | ﹤0.01% |
2,304,010
+79,409
| +4% | +$779K |
|
|
ONT
1871
Onterris Inc
ONT
$580M
| $18.1M | ﹤0.01% |
507,530
+18,522
| +4% | +$839K |
|
1872
Ichor Holdings
ICHR
$2.56B
| $18.1M | ﹤0.01% |
552,636
+16,033
| +3% | +$514K |
|
1873
Constellium
CSTM
$3.99B
| $18M | ﹤0.01% |
1,177,826
+76,448
| +7% | +$1.11M |
|
|
VTYX
1874
DELISTED
Ventyx Biosciences
VTYX
| $18M | ﹤0.01% |
537,142
+27,728
| +5% | +$1.08M |
|
1875
ZipRecruiter
ZIP
$423M
| $18M | ﹤0.01% |
1,128,829
+42,563
| +4% | +$769K |
|
Similar funds
Geode Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Geode Capital Management held 4,968 positions worth $770B, up 8.1% from $713B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q1 2023: portfolio turnover was 4.6%. Geode Capital Management opened 69 new positions and exited 162, leaving the 4,968-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q1 2023 buy was GE HealthCare: 6,775,612 shares worth $554M.
- Geode Capital Management added most to Microsoft in Q1 2023, an estimated $417M increase.
- Geode Capital Management's biggest Q1 2023 reduction was GE Aerospace, cutting an estimated $420M.
- Geode Capital Management fully exited SVB Financial Group in Q1 2023, selling an estimated $288M.
- Geode Capital Management's ten largest holdings make up 23% of its $770B portfolio in Q1 2023.
- Geode Capital Management opened 69 new positions and closed 162 in Q1 2023.
- Geode Capital Management's portfolio value rose 8.1% quarter-over-quarter to $770B.
Based on Geode Capital Management's 13F filing for Q1 2023, filed 15 May 2023.